All lobbying filings

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Lobbying for HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION · patient advocacy organization for individuals suffering from a rare disease

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Maryland · House · Senate · $10,000.00 income · posted Jul 17, 2025

Official filing document

Bills named in this filing 1

HR 4016
Department of Defense Appropriations Act, 2026

Lobbying activity 2

Defense

Hereditary Hemorrhagic Telanglectasia (HHT)

Health Issues

HR 4016/S unnumbered, FY26 Defense Appropriations Act, Peer Reviewed Medical Research Program designation for Hereditary Hemorrhagic Telangiectasia (HHT); HR unnumbered/S unnumbered, FY26 Labor HHS Education Appropriations Act, National HHT Center of Excellence Program

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.